GEOVAX
GeoVax Labs operates as a biotechnology company focusing on developing vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS). It was founded in 1988 and is based in Smyrna, Georgia, United States.
GEOVAX
Industry:
Biotechnology Health Care Medical Device
Founded:
1988-01-01
Address:
Smyrna, Georgia, United States
Country:
United States
Website Url:
http://www.geovax.com
Total Employee:
11+
Status:
Active
Contact:
6783847281
Email Addresses:
[email protected]
Total Funding:
28.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Apache
Similar Organizations
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - GeoVax
Official Site Inspections
http://www.geovax.com Semrush global rank: 1.34 M Semrush visits lastest month: 21.75 K
- Host name: sstwebdesign.sstwebdesign.com
- IP address: 170.249.217.130
- Location: West Chester United States
- Latitude: 39.9444
- Longitude: -75.5875
- Metro Code: 504
- Timezone: America/New_York
- Postal: 19382
More informations about "GeoVax"
GeoVax - Wikipedia
Formed in 2001 in Atlanta, Georgia, the approach was originally based on preclinical work done by Harriet Robinson from 1992 to 2002. In 2002, laboratory space, equipment and personnel were acquired and work on an HIV-1 vaccine development plan began. In May 2006, human clinical trials of the drug began. The company is now working on vaccines for Marburg, Lassa Fever, Ebola, Zika and Covid-19. See details»
Corporate Profile - GeoVax, Inc.
We also envision GeoVax as a preferred career-development organization to which highly …See details»
Company - GeoVax, Inc.
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human …See details»
GeoVax - Crunchbase Company Profile & Funding
GeoVax Labs operates as a biotechnology company focusing on developing vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS). It was founded in …See details»
GeoVax Labs, Inc. | LinkedIn
GeoVax Labs, Inc. | 2,844 followers on LinkedIn. Currently in Multiple Phase 2 Vaccine Trials | GeoVax Labs, Inc., (NASDAQ: GOVX) is a clinical-stage biotechnology company developing human ...See details»
GeoVax Labs Company Profile 2024: Stock Performance
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and …See details»
GeoVax Advances COVID-19 Vaccine with Up to $45M …
Jun 26, 2024 GeoVax has grown its workforce to about 25 people, Dodd said, up from the 17 the company reported in its Form 10-K annual report for 2023. That workforce is expected to grow over time through a ...See details»
Geovax Labs (GOVX-Q) Stock Price and News - The Globe and Mail
Real-time Price Updates for Geovax Labs (GOVX-Q), along with buy or sell indicators, …See details»
GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine …
Jan 11, 2021 --via NewMediaWire-- GeoVax Labs, Inc., a biotechnology company developing …See details»
GeoVax's stock soars 43% to lead rally in companies ... - Morningstar
Aug 19, 2024 GeoVax's stock (GOVX) has gained 389% in the month to date, rallying ever …See details»
GeoVax Labs (Nasdaq:GOVX) - Stock Price, News & Analysis
6 days ago GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human …See details»
GeoVax Reports Third Quarter 2024 Financial Results and Provides ...
Nov 12, 2024 GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel …See details»
GeoVax to Report Third Quarter 2024 Financial Results and …
Nov 5, 2024 GeoVax to Host Conference Call at 4:30 PM ET. ATLANTA, Nov. 05, 2024 …See details»
GeoVax Reports Third Quarter 2024 Financial Results and Provides ...
Nov 12, 2024 GeoVax, Inc. Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b …See details»
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
GeoVax Labs is a clinical-stage biotech firm developing infectious disease vaccines and cancer …See details»
GeoVax Labs, Inc. | Insights
Apr 6, 2023 Already A Biomedtracker Subscriber? You have access to the full company …See details»
Why Are GeoVax Shares Trading Higher Today? - Benzinga
Aug 16, 2024 GeoVax Labs, Inc. GOVX, a company specializing in vaccine development, is …See details»
GOVX Stock Price Quote - Morningstar
3 days ago See the latest Geovax Labs Inc stock price (GOVX:XNAS), related news, …See details»
GeoVax - Company Profile - Tracxn
Oct 22, 2024 GeoVax ranks 346th among 2667 active competitors. 938 of its competitors are …See details»